FDA Plan for Generic Drug Names Gets Panned by FTC
At a hearing in September, Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, told senators on the Health, Education, Labor and Pensions subcommittee she hoped
Search the Roll Call archive by keyword, date, Congress, section, or tags.
At a hearing in September, Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, told senators on the Health, Education, Labor and Pensions subcommittee she hoped
Amendments that could have restored these provisions were withdrawn, and the ECAA was rushed through the Senate Health, Education, Labor and Pensions Committee for consideration on the Senate floor.